1. Pink Sheet
  2. >>Market Access

Obesity Drug Coverage In ACA Plans May Expand With Shift In Treatment Classification Standard

 
• By Cathy Kelly

Current drug classification standard was originally designed for the Medicare Part D program, which does not cover obesity drugs.

Change Could Accommodate New Generation Of Treatments • Source: Shutterstock

The Centers for Medicare and Medicaid Services is considering endorsing a different drug classification standard for private insurance plans serving the individual and small group markets that could encourage broader coverage of weight loss drugs.

The change could be timely for a new generation of obesity drugs currently fighting to overcome obstacles to coverage, including...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Market Access

More from Pink Sheet

New EFPIA President Hopes ‘Sanity Will Prevail’ In EU Pharma Reform Dialogs

 
• By Eliza Slawther

Stefan Oelrich, the newly-announced president of European pharma industry federation EFPIA says the EU pharma reform is “not an improvement on the status quo” in its current form.

UK Pilots Faster Setup Of Early Phase Oncology Trials

 
• By Vibha Sharma

Oncology trial sponsors in the UK are being invited to participate in a pilot that aims to tackle duplication and variation in pharmacy reviews, which are an important part of setting up clinical trials in the National Health Service.

US CDC Vaccine Committee Revives Thimerosal Debate: A Portent Of Things To Come?

 
• By Bridget Silverman

The new Advisory Committee on Immunization Practices voted for new recommendations on the decades-old thimerosal safety issue and lays intellectual groundwork to revisit other past controversies and decisions.